| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |